#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14830	16S	1529	1529	99.93	16S.l6.c30.ctg.1	1964	746.6	0	.	n	.	0	C451T	SNP	451	451	C	678	678	T	860	T,C	629,187	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14830	16S	1529	1529	99.93	16S.l6.c30.ctg.1	1964	746.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	911	C	854	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26626	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3682	721.6	0	.	n	.	0	T695C	SNP	695	695	T	1106	1106	C	787	C,T,G	734,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26626	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3682	721.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2382	2382	C	890	C	818	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26626	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3682	721.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2456	2456	A	876	A	821	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26626	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3682	721.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3008	3008	C	807	C	765	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	S84P	NONSYN	250	252	TCT	599	601	CCT	134;131;131	C;C;T	124;122;123	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	H102R	NONSYN	304	306	CAC	653	655	CGC	130;133;132	C;G;C,T	123;125;124,1	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	L130V	NONSYN	388	390	CTC	737	739	GTC	149;150;152	G;T;C	138;127;136	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	C135R	NONSYN	403	405	TGT	752	754	CGC	161;160;157	C;G;C	141;140;139	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	A137T	NONSYN	409	411	GCG	758	760	ACG	154;156;155	A;C;G	139;139;136	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	A167T	NONSYN	499	501	GCG	848	850	ACG	114;112;111	A;C;G	103;100;103	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	C194G	NONSYN	580	582	TGC	929	931	GGC	104;104;103	G;G;C	99;99;99	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	T204A	NONSYN	610	612	ACA	959	961	GCG	112;113;112	G;C;G	104;104;104	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	Y218L	NONSYN	652	654	TAT	1001	1003	TTG	98;97;97	T;T;G	90;87;89	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	E232G	NONSYN	694	696	GAA	1043	1045	GGG	58;58;57	G;G,A;G	58;57,1;55	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	G243V	NONSYN	727	729	GGA	1076	1078	GTA	75;75;75	G;T;A	69;69;69	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1106	1108	TCC	82;84;83	T;C;C	77;78;79	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	K259Q	NONSYN	775	777	AAA	1124	1126	CAA	107;111;109	C;A;A	97;100;99	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	0	.	p	.	0	A275V	NONSYN	823	825	GCG	1172	1174	GTG	138;137;136	G;T;G	128;123;126	.	.
folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586	1	1	539	1324	folP	852	852	93.66	folP.l15.c4.ctg.1	1489	88.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1031	1033	AGC	64;64;64	A;G;C	64;64;63	folP.Neisseria_meningitidis_serogroup_C_FAM18_v1_01586:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5312	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3489	151.7	1	SNP	p	S91F	1	.	.	271	273	TTC	628	630	TTC	190;189;188	T;T;C	180;178;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5312	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3489	151.7	1	SNP	p	D95G	1	.	.	283	285	GGC	640	642	GGC	176;174;175	G;G;C	166;165;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5312	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3489	151.7	1	SNP	p	G95N	0	.	.	283	285	GGC	640	642	GGC	176;174;175	G;G;C	166;165;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1410	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1185	118.1	1	SNP	p	G45D	0	.	.	133	135	GGC	416	418	GGC	180;179;178	G,T;G;C	163,1;163;164	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	710	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	979	72.2	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	155	A	143	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5812	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	198.3	1	SNP	p	D86N	0	.	.	256	258	GAC	617	619	GAC	219;217;218	G;A;C	201;197;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5812	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	198.3	1	SNP	p	R87W	0	.	.	259	261	CGT	620	622	CGT	221;219;222	C,A;G;T	206,1;203;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5812	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	198.3	1	SNP	p	S87R	1	.	.	259	261	CGT	620	622	CGT	221;219;222	C,A;G;T	206,1;203;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5812	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	198.3	1	SNP	p	R87I	0	.	.	259	261	CGT	620	622	CGT	221;219;222	C,A;G;T	206,1;203;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5812	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	198.3	1	SNP	p	S88P	0	.	.	262	264	TCC	623	625	TCC	218;219;221	T;C,G;C	202;201,1;205	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3886	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2510	153.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1417	1419	GGC	195;192;191	G;G;C,T	184;181;176,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1279	1281	GCC	195;195;198	G;C;C	182;181;182	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1282	1284	ATG	199;201;202	A;T;G,C	186;187;188,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1294	1296	ACC	192;190;188	A;C;C	175;176;178	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1294	1296	ACC	192;190;188	A;C;C	175;176;178	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1795	1797	ACC	200;201;199	A;C;C	181;181;180	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1849	1851	GCG	196;193;193	G;C;G	183;181;181	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1849	1851	GCG	196;193;193	G;C;G	183;181;181	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1972	1974	GGT	143;142;143	G;G,T;T	134;132,1;133	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1981	1983	AGC	143;144;143	A;G;C	135;135;134	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3674	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	158.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1999	2001	CCG	109;112;110	C,G;C;G	81,5;86;87	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5648	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3067	183.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1671	1673	CCG	216;217;217	C;C;G	193;194;191	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2076	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1731	118.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	137	C	120	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	0	.	p	.	0	G140R	NONSYN	418	420	GGA	724	726	AGA	224;227;226	A;G;A	213;217;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	934	936	AGA	244;239;241	A;G;A	232;229;230	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1072	1074	GAT	245;241;243	G,T;A;T	226,1;225;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	1	SNP	p	G120K	1	.	.	358	360	AAG	664	666	AAG	235;235;235	A;A;G	223;224;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	1	SNP	p	N121D	0	.	.	361	363	AAC	667	669	AAC	231;232;232	A;A;C	215;217;216	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2894	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1565	183.8	1	SNP	p	A121N	1	.	.	361	363	AAC	667	669	AAC	231;232;232	A;A;C	215;217;216	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11322	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4939	228.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1156	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	904	126.3	1	SNP	p	V57M	1	.	.	169	171	ATG	396	398	ATG	255;254;254	A;T;G	243;242;244	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
